Disclosure Of Entity's Operating Segments [Text Block]

GenSight Biologics S.A. - Filing #855040

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Disclosure of entity's operating segments [text block]
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Tax expense (income)
5,000 EUR
2,000 EUR
Profit (loss)
27,625,000 EUR
27,625,000 EUR
28,617,000 EUR
28,617,000 EUR
Assets
25,941,000 EUR
56,648,000 EUR
Cash flows from (used in) operating activities
33,753,000 EUR
17,139,000 EUR
Cash flows from (used in) investing activities
172,000 EUR
16,000 EUR
Cash flows from (used in) financing activities
95,000 EUR
23,739,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.